Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature.
Saved in:
| Title: | Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature. |
|---|---|
| Authors: | de Bernardi A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Cancer Reseach Center of Lyon, Lyon, France., Larrouquère L; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Cancer Reseach Center of Lyon, Lyon, France. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Jan 10; Vol. 13, pp. 1210873. Date of Electronic Publication: 2024 Jan 10 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
